GILEAD SCIENCES, INC. financials

  1. Home
  2. Financials
  3. GILD
GILD CIK 0000882095

Source: EDGAR filings · Built 2026-06-02T03:08:43Z

Custom taxonomy namespace: ffd

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow 9.46B 10.30B 7.42B 8.34B 10.80B 7.52B
EBITDA 12.79B 4.44B 10.26B 9.45B 11.95B 5.56B
Working Capital 6.53B 7.17B 4.80B 3.21B 3.16B 4.60B
Net Debt 17.98B 17.33B 19.57B 20.40B 21.95B 26.12B
Gross Margin 78.83% 78.26% 76.04% 79.26% 75.82% 24.02%
Operating Margin 34.04% 5.78% 28.05% 26.87% 36.32% 16.49%
Net Margin 28.90% 1.67% 20.89% 16.83% 22.80% 0.50%
Return on Equity (ROE) 37.48% 2.48% 24.81% 21.62% 29.55% 0.68%
Return on Assets (ROA) 14.42% 0.81% 9.12% 7.27% 9.16% 0.18%
Current Ratio 1.55× 1.60× 1.43× 1.29× 1.27× 1.40×
Debt-to-Equity 1.13× 1.41× 1.12× 1.22× 1.29× 1.76×
Effective Tax Rate 13.13% 30.58% 18.18% 21.47% 25.09% 94.67%
Cash Conversion Ratio 1.18× 22.56× 1.41× 1.98× 1.83× 66.41×
Accruals Ratio -0.03× -0.18× -0.04× -0.07× -0.08× -0.12×
SBC % of Revenue 3.04% 2.90% 2.82% 2.33% 2.33% 2.60%
CapEx Coverage 17.80× 20.70× 13.69× 12.46× 19.66× 12.57×
Free Cash Flow Per Share $7.53 $8.21 $5.90 $6.61 $8.56 $5.95

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 18.10× 243.08× 18.00× 23.59× 14.73× 582.60×
P/FCF 16.29× 11.25× 13.73× 12.98× 8.48× 9.79×
FCF Yield 6.14% 8.89% 7.28% 7.70% 11.79% 10.22%
EV / EBITDA 13.31× 29.81× 11.75× 13.48× 9.46× 17.84×
P/S 5.17× 4.00× 3.72× 3.92× 3.33× 2.96×
P/B 6.71× 5.95× 4.42× 5.04× 4.32× 4.01×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 29.44B 28.75B 27.12B 27.28B 27.30B 24.69B
Revenues — — — — — 24.69B
Cost of Goods and Services Sold 6.23B 6.25B 6.50B 5.66B 6.60B 4.57B
Gross Profit — — — — — 5.93B
Selling, General and Administrative Expense 5.77B 6.09B 6.09B 5.67B 5.25B 5.15B
Operating Income (Loss) 10.02B 1.66B 7.61B 7.33B 9.92B 4.07B
Income Tax Expense (Benefit) 1.29B 211.00M 1.25B 1.25B 2.08B 1.58B
Net Income (Loss) Attributable to Parent 8.51B 480.00M 5.67B 4.59B 6.22B 123.00M
Earnings Per Share, Basic $6.84 $0.38 $4.54 $3.66 $4.96 $0.10
Weighted Average Number of Shares Outstanding, Basic 1.24B 1.25B 1.25B 1.25B 1.26B 1.26B
Earnings Per Share, Diluted $6.78 $0.38 $4.50 $3.64 $4.93 $0.10
Weighted Average Number of Shares Outstanding, Diluted 1.25B 1.25B 1.26B 1.26B 1.26B 1.26B

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value — — — 5.41B 5.34B 6.00B
Assets, Current 18.34B 19.17B 16.09B 14.44B 14.77B 16.00B
Assets 59.02B 58.99B 62.13B 63.17B 67.95B 68.41B
Long-term Debt 24.94B 26.71B 24.99B 25.23B 26.70B 31.40B
Liabilities, Current 11.81B 12.00B 11.28B 11.24B 11.61B 11.40B
Long-term Debt, Excluding Current Maturities 22.13B 24.90B 23.19B 22.96B 25.18B 28.64B
Stockholders' Equity Attributable to Parent 22.70B 19.33B 22.83B 21.24B 21.07B 18.20B
Common Stock, Shares, Outstanding 1.24B 1.25B 1.25B 1.25B 1.25B 1.25B

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 10.02B 10.83B 8.01B 9.07B 11.38B 8.17B
Payments to Acquire Property, Plant, and Equipment 563.00M 523.00M 585.00M 728.00M 579.00M 650.00M
Net Cash Provided by (Used in) Investing Activities -4.79B -3.45B -2.27B -2.47B -3.13B -14.62B
Payments for Repurchase of Common Stock 1.92B 1.15B 1.00B 1.40B 546.00M 1.58B
Payments of Dividends 4.00B 3.92B 3.81B 3.71B 3.60B 3.45B
Net Cash Provided by (Used in) Financing Activities -7.75B -3.43B -5.13B -6.47B -8.88B 770.00M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (GILD CIK 0000882095), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

FLO

FLOWERS FOODS, INC

PB

PROSPERITY BANCSHARES, INC.

ADPT

ADAPTIVE BIOTECHNOLOGIES CORPORATION